Report Detail

Pharma & Healthcare Global Biopharmaceuticals Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4511516
  • |
  • 16 February, 2023
  • |
  • Global
  • |
  • 104 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
According to our (Global Info Research) latest study, the global Biopharmaceuticals Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biopharmaceuticals Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biopharmaceuticals Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biopharmaceuticals Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biopharmaceuticals Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biopharmaceuticals Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biopharmaceuticals Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biopharmaceuticals Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma and JRS Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biopharmaceuticals Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biologics
Biosimilars
Market segment by Application
Process Development
Packaging
Others
Market segment by players, this report covers
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biopharmaceuticals Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biopharmaceuticals Contract Manufacturing, with revenue, gross margin and global market share of Biopharmaceuticals Contract Manufacturing from 2018 to 2023.
Chapter 3, the Biopharmaceuticals Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biopharmaceuticals Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceuticals Contract Manufacturing.
Chapter 13, to describe Biopharmaceuticals Contract Manufacturing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Biopharmaceuticals Contract Manufacturing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biopharmaceuticals Contract Manufacturing by Type
    • 1.3.1 Overview: Global Biopharmaceuticals Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type in 2022
    • 1.3.3 Biologics
    • 1.3.4 Biosimilars
  • 1.4 Global Biopharmaceuticals Contract Manufacturing Market by Application
    • 1.4.1 Overview: Global Biopharmaceuticals Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Process Development
    • 1.4.3 Packaging
    • 1.4.4 Others
  • 1.5 Global Biopharmaceuticals Contract Manufacturing Market Size & Forecast
  • 1.6 Global Biopharmaceuticals Contract Manufacturing Market Size and Forecast by Region
    • 1.6.1 Global Biopharmaceuticals Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Biopharmaceuticals Contract Manufacturing Market Size by Region, (2018-2029)
    • 1.6.3 North America Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Boehringer Ingelheim
    • 2.1.1 Boehringer Ingelheim Details
    • 2.1.2 Boehringer Ingelheim Major Business
    • 2.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.1.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.2 Lonza Group AG
    • 2.2.1 Lonza Group AG Details
    • 2.2.2 Lonza Group AG Major Business
    • 2.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.2.4 Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Lonza Group AG Recent Developments and Future Plans
  • 2.3 Inno Biologics Sdn Bhd
    • 2.3.1 Inno Biologics Sdn Bhd Details
    • 2.3.2 Inno Biologics Sdn Bhd Major Business
    • 2.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.3.4 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Inno Biologics Sdn Bhd Recent Developments and Future Plans
  • 2.4 Rentschler Biopharma
    • 2.4.1 Rentschler Biopharma Details
    • 2.4.2 Rentschler Biopharma Major Business
    • 2.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.4.4 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Rentschler Biopharma Recent Developments and Future Plans
  • 2.5 JRS Pharma
    • 2.5.1 JRS Pharma Details
    • 2.5.2 JRS Pharma Major Business
    • 2.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.5.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 JRS Pharma Recent Developments and Future Plans
  • 2.6 AGC Biologics
    • 2.6.1 AGC Biologics Details
    • 2.6.2 AGC Biologics Major Business
    • 2.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.6.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 AGC Biologics Recent Developments and Future Plans
  • 2.7 ProBioGen
    • 2.7.1 ProBioGen Details
    • 2.7.2 ProBioGen Major Business
    • 2.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.7.4 ProBioGen Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 ProBioGen Recent Developments and Future Plans
  • 2.8 FUJIFILM Diosynth Biotechnologies
    • 2.8.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.8.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.8.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.9 Toyobo Co., Ltd.
    • 2.9.1 Toyobo Co., Ltd. Details
    • 2.9.2 Toyobo Co., Ltd. Major Business
    • 2.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.9.4 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Toyobo Co., Ltd. Recent Developments and Future Plans
  • 2.10 Samsung Biologics
    • 2.10.1 Samsung Biologics Details
    • 2.10.2 Samsung Biologics Major Business
    • 2.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.10.4 Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Samsung Biologics Recent Developments and Future Plans
  • 2.11 Thermo Fisher Scientific
    • 2.11.1 Thermo Fisher Scientific Details
    • 2.11.2 Thermo Fisher Scientific Major Business
    • 2.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.11.4 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.12 Binex Co., Ltd.
    • 2.12.1 Binex Co., Ltd. Details
    • 2.12.2 Binex Co., Ltd. Major Business
    • 2.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.12.4 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Binex Co., Ltd. Recent Developments and Future Plans
  • 2.13 WuXi Biologics
    • 2.13.1 WuXi Biologics Details
    • 2.13.2 WuXi Biologics Major Business
    • 2.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.13.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 WuXi Biologics Recent Developments and Future Plans
  • 2.14 AbbVie, Inc.
    • 2.14.1 AbbVie, Inc. Details
    • 2.14.2 AbbVie, Inc. Major Business
    • 2.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product and Solutions
    • 2.14.4 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 AbbVie, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biopharmaceuticals Contract Manufacturing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Biopharmaceuticals Contract Manufacturing by Company Revenue
    • 3.2.2 Top 3 Biopharmaceuticals Contract Manufacturing Players Market Share in 2022
    • 3.2.3 Top 6 Biopharmaceuticals Contract Manufacturing Players Market Share in 2022
  • 3.3 Biopharmaceuticals Contract Manufacturing Market: Overall Company Footprint Analysis
    • 3.3.1 Biopharmaceuticals Contract Manufacturing Market: Region Footprint
    • 3.3.2 Biopharmaceuticals Contract Manufacturing Market: Company Product Type Footprint
    • 3.3.3 Biopharmaceuticals Contract Manufacturing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biopharmaceuticals Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
  • 6.2 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
  • 6.3 North America Biopharmaceuticals Contract Manufacturing Market Size by Country
    • 6.3.1 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
  • 7.2 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
  • 7.3 Europe Biopharmaceuticals Contract Manufacturing Market Size by Country
    • 7.3.1 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 7.3.3 France Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Size by Region
    • 8.3.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2018-2029)
    • 8.3.2 China Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 8.3.5 India Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
  • 9.2 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
  • 9.3 South America Biopharmaceuticals Contract Manufacturing Market Size by Country
    • 9.3.1 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Country
    • 10.3.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Biopharmaceuticals Contract Manufacturing Market Drivers
  • 11.2 Biopharmaceuticals Contract Manufacturing Market Restraints
  • 11.3 Biopharmaceuticals Contract Manufacturing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Biopharmaceuticals Contract Manufacturing Industry Chain
  • 12.2 Biopharmaceuticals Contract Manufacturing Upstream Analysis
  • 12.3 Biopharmaceuticals Contract Manufacturing Midstream Analysis
  • 12.4 Biopharmaceuticals Contract Manufacturing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biopharmaceuticals Contract Manufacturing. Industry analysis & Market Report on Biopharmaceuticals Contract Manufacturing is a syndicated market report, published as Global Biopharmaceuticals Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Biopharmaceuticals Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,766.60
    4,149.90
    5,533.20
    3,219.00
    4,828.50
    6,438.00
    544,341.60
    816,512.40
    1,088,683.20
    290,684.40
    436,026.60
    581,368.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report